SURAKSHA2024-10-012024-12-31 SURAKSHA2024-10-012024-12-31 SURAKSHA2024-10-012024-12-31in-bse-fin:OneOperatingExpenses01Member SURAKSHA2024-10-012024-12-31in-bse-fin:OneOperatingExpenses02Member SURAKSHA2024-10-012024-12-31in-bse-fin:OneOperatingExpenses03Member SURAKSHA2024-10-012024-12-31in-bse-fin:OneOperatingExpenses04Member SURAKSHA2024-10-012024-12-31in-bse-fin:OneOperatingExpenses05Member SURAKSHA2024-10-012024-12-31in-bse-fin:OneOperatingExpenses06Member SURAKSHA2024-10-012024-12-31in-bse-fin:OneOperatingExpenses07Member SURAKSHA2024-10-012024-12-31in-bse-fin:OneOperatingExpenses08Member SURAKSHA2024-10-012024-12-31in-bse-fin:OneOperatingExpenses09Member SURAKSHA2024-10-012024-12-31in-bse-fin:OneOperatingExpenses10Member SURAKSHA2024-10-012024-12-31in-bse-fin:FourOperatingExpenses01Member SURAKSHA2024-10-012024-12-31in-bse-fin:FourOperatingExpenses02Member SURAKSHA2024-10-012024-12-31in-bse-fin:FourOperatingExpenses03Member SURAKSHA2024-10-012024-12-31in-bse-fin:FourOperatingExpenses04Member SURAKSHA2024-10-012024-12-31in-bse-fin:FourOperatingExpenses05Member SURAKSHA2024-10-012024-12-31in-bse-fin:FourOperatingExpenses06Member SURAKSHA2024-10-012024-12-31in-bse-fin:FourOperatingExpenses07Member SURAKSHA2024-10-012024-12-31in-bse-fin:FourOperatingExpenses08Member SURAKSHA2024-10-012024-12-31in-bse-fin:FourOperatingExpenses09Member SURAKSHA2024-10-012024-12-31in-bse-fin:FourOperatingExpenses10Member SURAKSHA2024-12-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 544293 SURAKSHA NA Suraksha Diagnostic Limited Equity 2024-04-01 2025-03-31 2025-02-08 2025-02-03 INR Lakhs Third quarter 16:00:00 16:32:00 2025-02-08 2025-02-08 Not applicable Single segment DIAGNOSTIC 2024-10-01 2024-12-31 Unaudited Consolidated 595130000.00 5991000.00 601121000.00 61032000.00 0.00 0.00 112866000.00 19815000.00 88272000.00 238669000.00 520654000.00 80467000.00 0.00 80467000.00 21541000.00 -920000.00 20621000.00 0.00 59846000.00 0.00 0.00 0.00 0.00 59846000.00 1224000.00 61070000.00 61536000.00 -1690000.00 104162000.00 2 1.18 1.18 0.00 0.00 1.18 1.18 1. The unaudited consolidated financial results for the quarter and nine months period ended December 31, 2024 (“the financial results”) of Suraksha Diagnostic Limited (Formerly known as Suraksha Diagnostic Private Limited) (“the Holding Company”) and its subsidiary (Holding company and subsidiaries together referred to as ‘the group’) have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard (Ind AS) notified under Section 133 of the Companies Act, 2013, as amended, read with relevant rules thereunder and other accounting principles generally accepted in India and in accordance with Regulation 33 of the SEBI (Listing) Obligations and Disclosure Requirements) Regulations, 2015, as amended (“the regulations”). 2. These financial results have been reviewed and recommended by the Audit Committee and approved by the Board of Directors in their respective meeting held on February 08, 2025. The statutory auditors have carried out limited review on these financial results and have issued an unmodified conclusion. 3. The figures for the corresponding quarter and nine months period ended December 31, 2023 are presented based on the information complied by the management in accordance with Ind AS and have not been subject to review or audit by the statutory auditors or by any other auditor. However, the management has prepared the results for the said periods by applying consistent accounting policies. 4. During the quarter ended December 31, 2024, the Holding company has completed an initial Public Offering entirely as offer for sale of 1,91,89,330 equity shares by existing share holders with face value of Rs.2 and listed on both National Stock exchange (NSE) and Bombay Stock Exchange (BSE) on December 06, 2024. 5. The Group is primarily engaged in the business of diagnostic centres for carrying out various pathology and radiology services and as such there are no separate reportable segments as per Ind AS 108 –‘Operating Segments’. 6. The figures for the year ended March 31, 2024 have been extracted from the general purpose consolidated financial statements of the Company which were audited by the statutory auditors of the Company. 7. During the quarter ended December 31, 2024, 0.0001% Compulsorily Convertible Preference Shares of the Holding company aggregating to 1,62,859 preference shares of par value Rs 100 each were converted into 89,55,761 equity shares of par value of Rs 2 each. 8. During the quarter ended December 31, 2024, the Nomination and Remuneration Committee ( the NRC ) has approved grant of 2,08,164 stock options to employees under the Suraksha Employee Stock Option Scheme 2024 ( the Scheme ). The Holding company has accounted for these stock options in accordance with Ind AS 102 – Share-Based Payments 9. These financial results are also available on the Holding company's website (www.surakshanet.com) and on the stock exchange websites (www.bseindia.com and www.nseinda.com). Single segment 2024-04-01 2024-12-31 Unaudited Consolidated 1869980000.00 30292000.00 1900272000.00 206711000.00 0.00 0.00 326869000.00 63220000.00 265689000.00 715855000.00 1578344000.00 321928000.00 0.00 321928000.00 88230000.00 -4372000.00 83858000.00 0.00 238070000.00 0.00 0.00 0.00 0.00 238070000.00 -1405000.00 236665000.00 244354000.00 -6284000.00 104162000.00 2 4.69 4.69 0.00 0.00 4.69 4.69 Advertisement 9660000.00 Commission to collection centres 6697000.00 Information technology expenses 13558000.00 Other Expenses 34071000.00 Power and fuel 20752000.00 Professional fees paid to doctors 101160000.00 Rent Expense 10145000.00 Repairs and maintenance 19010000.00 Sample testing and collection charges 8428000.00 Security and housekeeping charges 15188000.00 Advertisement 27719000.00 Commission to collection centres 25445000.00 Information technology expenses 37612000.00 Other Expenses 94911000.00 Power and fuel 61686000.00 Professional fees paid to doctors 313673000.00 Rent Expense 26935000.00 Repairs and maintenance 58651000.00 Sample testing and collection charges 25986000.00 Security and housekeeping charges 43237000.00 1224000.00 -1405000.00 0.00 0.00 0.00 0.00